I

Immatics NV
D

IMTX

7.13500
USD
0.13
(1.78%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
61,993
الربح لكل سهم
-2
العائد الربحي
-
P/E
-4
حجم السوق
1,086,125,924
أصول ذات صلة

العنوان: Immatics NV

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.